Emergent Biosolutions Inc
EBS
$6.89-1.36%
Delayed · as of Oct 13, 2026, 3:15 PM ET
Mkt cap
$416.38M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$742.90M
EPS (H1 2026)
$-3.35
Gross Margin (FY2025)
56.09%
Profit Margin (FY2025)
7.08%
Beta
2.33
Div yield
N/A
Sector
Healthcare
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported EBS revenue for 2025-12-31 was $742.9M. Net income was $52.6M. Revenue was down 28.8% from 2024-12-31 to 2025-12-31. EBS currently screens at market cap $416.4M.
Use this EBS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full EBS income, balance, and cash tables.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Emergent Biosolutions Inc (EBS) revenue for Dec 31, 2025 was $742.9M. Net income was $52.6M. Statements: https://lician.com/financials/ebs
Emergent Biosolutions Inc (EBS) market capitalization is $416.4M on the latest cached snapshot.
Emergent Biosolutions Inc (EBS) cached previous close $6.98; day range $6.89 – $6.95; volume 297,051. Session quote: https://lician.com/quote/ebs
Emergent Biosolutions Inc (EBS) latest cached earnings event is "EBS earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached EBS filing is 8-K · Oct 16, 2026. Filings: https://lician.com/sec/ebs